Baofeng Guo
Impact in
- Biotechnology top 2%
- Cancer Research and Treatments
- Cancer Research top 10%
- MicroRNA in disease regulation
Papers in
-
- RNA Interference and Gene Delivery 12
- Protein Degradation and Inhibitors 3
- Oncology 15
- Cytokine Signaling Pathways and Interactions 5
- Co-authors
- Xuejian Zhao (14 shared papers)Libo Xu (16 shared papers)Ling Zhang (8 shared papers)Dennis J. Kopecko (6 shared papers)Ding Wang (10 shared papers)De-Qi Xu (8 shared papers)Di Yin (5 shared papers)Yang Li (7 shared papers)
- Journals
- Biochemical Pharmacology (4 papers)Oncotarget (3 papers)Asian Journal of Andrology (3 papers)Frontiers in Immunology (2 papers)Cancer Gene Therapy (2 papers)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Baofeng Guo
55 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 88
- Biotechnology 235
- Cancer Research 175
- Biomedical Engineering 329
- Molecular Biology 513
- Oncology 185
Countries citing papers authored by Baofeng Guo
This map shows the geographic impact of Baofeng Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baofeng Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baofeng Guo more than expected).
Fields of papers citing papers by Baofeng Guo
This network shows the impact of papers produced by Baofeng Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baofeng Guo. The network helps show where Baofeng Guo may publish in the future.
Co-authors
The 25 scholars most cited alongside Baofeng Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 118 | |
| 2 | 2013 | 93 | |
| 3 | 2019 | 68 | |
| 4 | 2012 | 62 | |
| 5 | 2021 | 45 | |
| 6 | 2017 | 36 | |
| 7 | 2013 | 35 | |
| 8 | 2012 | 33 | |
| 9 | 2011 | 32 | |
| 10 | 2015 | 29 | |
| 11 | 2016 | 29 | |
| 12 | 2017 | 29 | |
| 13 | 2009 | 27 | |
| 14 | 2020 | 25 | |
| 15 | 2013 | 23 | |
| 16 | 2016 | 21 | |
| 17 | 2013 | 20 | |
| 18 | 2021 | 20 | |
| 19 | 2008 | 20 | |
| 20 | 2011 | 18 |
About Baofeng Guo
Baofeng Guo is a scholar working on Molecular Biology, Oncology, Biomedical Engineering, Genetics and Biotechnology, having authored 57 papers that have together received 1.1k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (12 papers), Nanoplatforms for cancer theranostics (10 papers), Cancer Research and Treatments (10 papers), Virus-based gene therapy research (8 papers), Nanoparticle-Based Drug Delivery (6 papers), Cytokine Signaling Pathways and Interactions (5 papers), Graphene and Nanomaterials Applications (5 papers) and Protein Degradation and Inhibitors (3 papers). The work is most often cited by research in Biotechnology (235 citations), Cancer Research (175 citations), Biomedical Engineering (329 citations), Molecular Biology (513 citations) and Oncology (185 citations). Baofeng Guo has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Xuejian Zhao, Libo Xu, Ling Zhang, Dennis J. Kopecko, Ding Wang, De-Qi Xu, Di Yin, Yang Li, Xin Li and Dhan V. Kalvakolanu. Their work appears in journals such as Biochemical Pharmacology, Oncotarget, Asian Journal of Andrology, Frontiers in Immunology and Cancer Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.